Sponsored Content | Webinar | Proton Therapy| October 13, 2016

WEBINAR: Economics of Establishing a Proton Therapy Center

This webinar is sponsored by IBA

IBA, proton therapy, economics of proton therapy, ROI of proton therapy, Proteus One

The webinar "Economics of Establishing a Proton Therapy Center," will help educate hospitals and oncology centers about the economics of building a proton therapy center and how it can potentially expand oncology services. IBA will take the mystery out of establishing a proton therapy center by walking attendees through the cost, staff, ROI and reimbursement management for a proton therapy center.

The webinar takes place Thursday, Nov. 3, 2016, 2-3 p.m. Eastern Time

Register for this webinar

 

Speakers

Joy Godby, BA, ROCC
Associate Director for Radiation Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Godby manages the entire revenue cycle for radiation oncology (billing, coding, patient access, financial counseling, upfront appeals and back end appeals for all modalities). Her talk "Managing the Maze of Insurance authorization for Radiation Therapy" includes insights to reimbursement for oncology services.

 

Robert McElearney MBA
Vice President Strategic Accounts
IBA Proton Therapy North America

McElearney’s background in healthcare spans almost 20 years, working in every part of the country in senior positions of leadership in the healthcare industry. He led business development for the nation’s largest provider of mobile imaging services, directing its effort to expand into new business areas. McElearney provides overall new business leadership for IBA Inc. in partnering with health facilitates in developing a Proton Therapy Center.

 

Mary Elizabeth (Beth) Klein,
President, IBA Proton Therapy North America

Klein joined IBA in 2009, after more than 25 years with GE Healthcare. There she held various leadership roles including leading the nuclear medicine business and was the Americas commercial executive at TomoTherapy 2005-2007.

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer.s. The company is the worldwide technology leader in the field of proton therapy, which is considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.

Headquartered in Belgium and employing about 1300 people worldwide, IBA has installed systems across the world. IBA is listed on the Pan-European stock exchange NYSE EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com

 

Register for this webinar

Related Content

University of Wisconsin-Madison Partners With RaySearch on RayCare OIS
News | Oncology Information Management Systems (OIMS) | June 21, 2017
The Department of Human Oncology at the University of Wisconsin-Madison has entered into an agreement with RaySearch to...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
Henry Ford Cancer Institute First in World to Install Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer patients advanced...
Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

IMAGE OF THE YEAR: Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer. Technology of dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of metastases. This work might help to establish a new treatment regimen for more precise and sensitive pre-, intra- and post-therapeutic detection of prostate cancer.

Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center, Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, Heidelberg University Hospital, Heidelberg, Germany; PET-image: Afshar-Oromieh et al., EJNMMI 2013; 40(4); STED-image: J. Matthias, German Cancer Research Center.

This study was supported by the VIP+ fund, Federal Ministry of Education & Research (BMBF), Germany.

Scientific Paper 531: “Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer.” A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany; T. Simpfendörfer, B.  Hadaschik, U. Haberkorn, University Hospital, Heidelberg, Germany. Presented at SNMMI’s 64th Annual Meeting, June 10-14, 2017, Denver, Colo.

News | Prostate Cancer | June 15, 2017
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may...
Versa

Image courtesy of Elekta

News | Radiation Therapy | June 13, 2017
Radiation therapy (RT) using high-energy particles, like X-rays or electron beams, is a common and critical component...
News | Radiation Oncology | June 12, 2017
The alliance will study the feasibility of using CRnR’s converging x-ray lens technology as an effective radiotherapy...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Sponsored Content | Case Study | Radiation Therapy | June 08, 2017
Stereotactic body radiation therapy (SBRT) employs significantly higher per fraction radiation doses than conventional...
pediatric imaging
News | Radiation Oncology | June 08, 2017
In an article published in the June 2017 issue of The Journal of Nuclear Medicine, researchers assert that e
Feature | Radiation Therapy | June 07, 2017 | By Melinda Taschetta-Millane
According to the National Institutes of Health (NIH), precision-based medicine is an emerging approach for disease tr
Overlay Init